Search Ontology:
ChEBI

mirodenafil

Term ID
CHEBI:136049
Synonyms
  • 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
  • mirodenafil
  • mirodenafilo
  • mirodenafilum
  • SK-3530
  • SK3530
Definition
A member of the class of pyrrolopyrimidines that is 3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one having a 5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl group at positon 2, ethyl group at position 5, and a propyl group at position 7. It is a phosphodiesterase type 5 inhibitor which is used for the treatment of erectile dysfunction.
References
  • cas:862189-95-5
  • chemspider:10173481
  • drugbank:DB11792
  • drugcentral:5005
  • patent:KR20080062434
  • pubmed:18098061
  • pubmed:19057138
  • pubmed:19095395
  • pubmed:19639551
  • pubmed:19929308
  • pubmed:20456834
  • pubmed:20649936
  • pubmed:20861845
  • pubmed:21162118
  • pubmed:21478894
  • pubmed:22692776
  • pubmed:22921287
  • pubmed:23006442
  • pubmed:23017527
  • pubmed:23303333
  • pubmed:23390072
  • pubmed:23700501
  • pubmed:23937271
  • pubmed:24219508
  • pubmed:24872948
  • pubmed:25162329
  • pubmed:25606563
  • pubmed:25833477
  • pubmed:26919966
  • pubmed:27034723
  • pubmed:32388784
  • pubmed:32981502
  • wikipedia.en:Mirodenafil
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from mirodenafil
Phenotype where environments contain mirodenafil
Phenotype modified by environments containing mirodenafil
Phenotype affecting mirodenafil
Human Disease Model